In vitro susceptibilities to amphotericin B, itraconazole, and miconazole of filamentous fungi isolated from patients with cystic fibrosis

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 9, 1997, Pages 2064-2066

  Hennequin, C ^a   Benailly, N ^a   Silly, C ^a   Sorin, M ^a   Scheinmann, P ^a   Lenoir, G ^a   Gaillard, J L ^a   Berche, P ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; MICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS; CYSTIC FIBROSIS; FUNGUS IDENTIFICATION; HUMAN; INFECTION RISK; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL;

EID: 0030845345     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.9.2064     Document Type: Article

References (19)

1. Chabasse, D., J. P. Bouchara, J. P. Chazalette, J. Carrère, J. L. Ginies, L. De Gentille, and B. Cimon. 1991. Mucoviscidose et colonisation fongique à Scedosporium apiospermum. J. Mycol. Méd. 1:152-155.
2. Chung, Y., J. R. Kraut, A. M. Stone, and J. Valaitis. 1994. Disseminated aspergillosis in a patient with cystic fibrosis and allergic bronchopulmonary aspergillosis. Pediatr. Pulmonol. 17:131-134.
3. Cimon, B., J. Carrère, J. P. Chazalette, J. L. Ginies, P. Six, J. F. Vinatier, D. Chabasse, and J. P. Bouchara. 1995. Fungal colonisation and immune response to fungi in cystic fibrosis. J. Mycol. Méd. 5:211-216.
4. Denning, D. W., R. M. Tucker, L. H. Hanson, and D. A. Stevens. 1989. Treatment of invasive aspergillosis with itraconazole. Am. J. Med. 86:791-800.
5. Denning, D. W., J. Van Wye, N. J. Lewinston, and D. A. Stevens. 1991. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest 100:813-819.
6. Drent, M., M. T. Van Rens, S. S. Wagenaar, B. M. De Jongh, H, Van Velzen Blad, and J. M. Van Den Bosch. 1995. Invasive aspergillosis after bilateral lung transplantation in cystic fibrosis. Respir. Med. 89:449-451.
7. Espinel-Ingroff, A., and T. M. Kerkering. 1991. Spectrophotometric method of inoculum preparation for the in vitro susceptibility testing of filamentous fungi. J. Clin. Microbiol. 34:848-852.
8. Espinel-Ingroff, A., K. Dawson, M. Pfaller, E. Anaissie, B. Breslin, D. D., A. Fothergill, V. Paetznick, M. Rinaldi, and T. Walsh. 1995. Comparative and collaborative evaluation of standardisation of antifungal susceptibility testing of filamentous fungi. Antimicrob. Agents Chemother. 39:314-319.
9. Germaud, P., E. Tuchais, I. Canfrère, M. De Lajarte, E. Chailleux, and M. Delobel. 1992. Therapy of allergic bronchopulmonary aspergillosis with itraconazole. Am. Rev. Respir. Dis. 145:A736.
10. Gilligan, P. H. 1991. Microbiology of airway disease in patients with cystic fibrosis. Clin. Microbiol. Rev. 4:35-51.
11. Knutsen, A. P., and R. G. Slavin. 1992. Allergic bronchopulmonary mycosis complicating cystic fibrosis. Semin. Respir. Infect. 7:179-192.
12. Kwon-Chung, K. J., and J. E. Bennett. 1992. Infections due to miscellaneous molds, p. 733-767. In K. J. Kwon-Chung and J. E. Bennett (ed.), Medical mycology, 1st ed. Lea & Febiger, Philadelphia, Pa.
13. Manavathu, E. K., G. J. Alangaden, and S. A. Lerner. 1995. Isolation and characterization of itraconazole resistant mutants of Aspergillus fumigatus, abstr. C100. In Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
14. Mannes, G. P. M., S. Van der Heide, W. M. C. Van Aalderren, and J. Gerritsen. 1993. Itraconazole and allergic bronchopulmonary aspergillosis in twin brothers with cystic fibrosis. Lancet 341:492.
15. Miller, M. A., P. A. Greenberger, R. American, J. H. Toogood, G. A. Noskin, M. Roberts, and R. Patterson. 1993. Allergic bronchopulmonary mycosis caused by Pseudallescheria boydii. Am. Rev. Respir. Dis. 148:810-812.
16. Mroueh, S., and A. Spock. 1994. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Chest 105:32-36.
17. Muir, A., R. F. Selden, T. A. E. Platts Mills, and L. K. Chapman. 1994. Antibody responses to A. fumigatus in patients with cystic fibrosis and their use of markers of treatment with itraconazole. J. Allergy Clin. Immunol. 13:228.
18. National Committee for Clinical Laboratory Standards. 1992. Reference method for broth dilution susceptibility antifungal testing for yeast. Proposed standard. Document M27-P. National Committee for Clinical Laboratory Standards, Villanova, Pa.
19. Pfaller, M. A., J. H. Rex, and M. G. Rinaldi. 1997. Antifungal susceptibility testing: technical advances and potential clinical applications. Clin. Infect. Dis. 24:776-784.